These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 26753066)
1. Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer. Ippolito D; Fior D; Trattenero C; Ponti ED; Drago S; Guerra L; Franzesi CT; Sironi S World J Radiol; 2015 Dec; 7(12):509-20. PubMed ID: 26753066 [TBL] [Abstract][Full Text] [Related]
2. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Ippolito D; Monguzzi L; Guerra L; Deponti E; Gardani G; Messa C; Sironi S Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580 [TBL] [Abstract][Full Text] [Related]
3. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039 [TBL] [Abstract][Full Text] [Related]
4. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer. Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318 [TBL] [Abstract][Full Text] [Related]
5. Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma. Byun BH; Kong CB; Lim I; Choi CW; Song WS; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM J Nucl Med; 2013 Jul; 54(7):1053-9. PubMed ID: 23670899 [TBL] [Abstract][Full Text] [Related]
6. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy. Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248 [TBL] [Abstract][Full Text] [Related]
8. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade. Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734 [TBL] [Abstract][Full Text] [Related]
9. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy. Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759 [TBL] [Abstract][Full Text] [Related]
10. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology. Koç M; Kaya GÇ; Demir Y; Sürücü E; Sarioğlu S; Obuz F; Öztop İ; Görken İB; Sökmen S Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176 [TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330 [TBL] [Abstract][Full Text] [Related]
12. Response assessment of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Is apparent diffusion coefficient useful on 3 T magnetic resonance imaging? Boraschi P; Cervelli R; Donati F; Landi E; Cacciato-Insilla A; Campani D; Caramella D Colorectal Dis; 2023 May; 25(5):905-915. PubMed ID: 36638020 [TBL] [Abstract][Full Text] [Related]
13. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275 [TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study. Genovesi D; Filippone A; Ausili Cèfaro G; Trignani M; Vinciguerra A; Augurio A; Di Tommaso M; Borzillo V; Sabatino F; Innocenti P; Liberatore E; Colecchia G; Tartaro A; Cotroneo AR Eur J Surg Oncol; 2013 Oct; 39(10):1071-8. PubMed ID: 23953231 [TBL] [Abstract][Full Text] [Related]
15. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731 [TBL] [Abstract][Full Text] [Related]
16. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485 [TBL] [Abstract][Full Text] [Related]
17. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer. Zhao M; Zhao L; Yang H; Duan Y; Li G Radiat Oncol; 2021 Jan; 16(1):17. PubMed ID: 33472660 [TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. Cascini GL; Avallone A; Delrio P; Guida C; Tatangelo F; Marone P; Aloj L; De Martinis F; Comella P; Parisi V; Lastoria S J Nucl Med; 2006 Aug; 47(8):1241-8. PubMed ID: 16883000 [TBL] [Abstract][Full Text] [Related]
19. Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study. Vuijk FA; Feshtali Shahbazi S; Noortman WA; van Velden FHP; Dibbets-Schneider P; Marinelli AWKS; Neijenhuis PA; Schmitz R; Ghariq E; Velema LA; Peters FP; Smit F; Peeters KCMJ; Temmink SJD; Crobach SALP; Putter H; Vahrmeijer AL; Hilling DE; de Geus-Oei LF Nucl Med Commun; 2023 Jul; 44(7):613-621. PubMed ID: 37132268 [TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology. De Cobelli F; Giganti F; Orsenigo E; Cellina M; Esposito A; Agostini G; Albarello L; Mazza E; Ambrosi A; Socci C; Staudacher C; Del Maschio A Eur Radiol; 2013 Aug; 23(8):2165-74. PubMed ID: 23588582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]